Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

RusHydro reported for 6 months of 2024 by RAS

7/31/24 HYDR

Chelyabinsk Metallurgical Plant will buy out Guryevsky Metallurgical Plant

7/31/24 MTLR

Chelyabinsk Metallurgical Plant will buy out Guryevsky Metallurgical Plant

7/31/24 CHMK

Mostotrest reported for 6 months of 2024 by RAS

7/31/24 MSTT

Severstal reported for 6 months of 2024 by RAS

7/31/24 CHMF

Super Lenta chain changes its design concept

7/31/24 LENT

Element creates serial production of power electronics

7/31/24 ELMT

Lukoil increased its network of charging stations by 1.7 times

7/31/24 LKOH

Samolet Plus has successfully completed Pre-IPO

7/31/24 SMLT

Samolet Plus has successfully completed Pre-IPO

7/31/24 OTCI